| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 59.98M | 61.41M | 70.61M | 72.78M | 59.25M | 47.98M |
| Gross Profit | 21.18M | 22.22M | 26.89M | 28.64M | 20.19M | 13.01M |
| EBITDA | -6.43M | -4.42M | 3.45M | 6.03M | 5.90M | 288.00K |
| Net Income | -11.19M | -10.69M | -2.17M | 1.63M | 16.22M | -11.69M |
Balance Sheet | ||||||
| Total Assets | 74.99M | 80.69M | 97.26M | 102.44M | 103.94M | 73.54M |
| Cash, Cash Equivalents and Short-Term Investments | 6.79M | 10.56M | 9.46M | 9.06M | 25.05M | 18.12M |
| Total Debt | 5.34M | 6.49M | 10.10M | 9.21M | 9.19M | 2.58M |
| Total Liabilities | 16.36M | 18.50M | 25.43M | 30.67M | 35.14M | 17.38M |
| Stockholders Equity | 58.62M | 62.18M | 71.83M | 71.77M | 68.80M | 52.39M |
Cash Flow | ||||||
| Free Cash Flow | 589.00K | 5.58M | -2.39M | -10.89M | -3.97M | -3.90M |
| Operating Cash Flow | 1.94M | 6.60M | -449.00K | -5.50M | -2.05M | -2.81M |
| Investing Cash Flow | -1.78M | -768.00K | 570.00K | -8.63M | 7.81M | -636.00K |
| Financing Cash Flow | -4.08M | -4.29M | -1.35M | -2.92M | -674.00K | -1.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Neutral | £83.66M | 18.26 | 9.34% | ― | 7.36% | 31.93% | |
68 Neutral | £90.93M | 37.56 | 3.88% | 1.56% | 8.75% | -54.73% | |
68 Neutral | £106.00M | 13.89 | 18.63% | ― | -3.41% | 58.10% | |
67 Neutral | £163.20M | 43.96 | 3.13% | 2.20% | 10.66% | 21.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | £80.60M | -7.21 | -16.64% | ― | -7.35% | -222.10% | |
54 Neutral | £200.25M | -2.87 | -31.42% | ― | -16.33% | -448.12% |
Xaar plc announced that its issued share capital comprises 79,783,945 ordinary shares, with no shares held in treasury. This announcement is in accordance with the FCA’s Disclosure and Transparency Rules, and the total voting rights figure will be used by shareholders to assess their interests in the company.
Xaar plc announced a transaction involving the lapse of share options under the Xaar 2017 Sharesave Plan by Graham Tweedale, the Chief Operating Officer and Person Discharging Managerial Responsibilities. This transaction, involving 3,857 shares at a price of £1.40 each, was conducted outside a trading venue and reflects the company’s adherence to the UK Market Abuse Regulation, ensuring transparency and regulatory compliance.
Xaar plc has announced its total voting rights, with the company’s issued share capital consisting of 79,783,945 ordinary shares as of October 31, 2025. This figure is crucial for shareholders to determine their required notifications under the FCA’s Disclosure and Transparency Rules, impacting how stakeholders manage their interests in the company.
Xaar plc, a leader in the field of inkjet printing technology, has announced a significant transaction involving its Chief Operating Officer, Graham Tweedale. On 21 October 2025, Tweedale was granted options over 5,673 ordinary shares at a price of £1.068 each under the company’s 2017 Sharesave Plan. This move is part of Xaar’s ongoing efforts to align management interests with shareholder value, potentially impacting the company’s operational focus and market positioning.
Xaar plc announced a transaction involving its Non-Executive Director, Ms. Jacqueline Sutton, who purchased 4,107 ordinary shares at a price of £1.20825 per share. This transaction, conducted in London, is part of the regulatory requirements under the UK Market Abuse Regulation, highlighting the company’s commitment to transparency and compliance.
Xaar plc, a company involved in the technology sector, announced a transaction involving its Non-Executive Director, Mr. Ben Stocks. The transaction, which took place on October 1, 2025, involved the purchase of 16,114 ordinary shares by Mrs. Sara Stocks, Mr. Stocks’ wife, at a price of £1.285 per share. This transaction was conducted in accordance with the UK Market Abuse Regulation and has been duly notified to the Financial Conduct Authority.
Xaar plc announced a transaction involving Dr. Inken Braunschmidt, a Non-Executive Director, who purchased 4,000 ordinary shares at a price of £1.28 per share. This transaction, compliant with UK Market Abuse Regulation, reflects confidence in the company’s future prospects and may influence stakeholder perceptions positively.
Xaar plc announced that its issued share capital comprises 79,767,612 ordinary shares, with no shares held in treasury. This figure is significant for shareholders for calculating their interests under the FCA’s Disclosure and Transparency Rules, impacting how they manage their stakes in the company.
Xaar plc has announced a trading update, maintaining confidence in its financial performance for the year ending 31 December 2025, with new market initiatives progressing as planned. The company has identified historic tax liabilities in an overseas jurisdiction, estimated between £3 million and £4 million, which are not expected to affect future trading. Additionally, Ben Stocks has joined as Chairman and Independent Non-Executive Director, expressing optimism about Xaar’s growth potential.